|
1
|
Canadian Cardiovascular Society American
Academy of Family Physicians American College of Cardiology;
American Heart Association; Antman EM, Hand M, Armstrong PW, Bates
ER, Green LA, Halasyamani LK, et al: 2007 focused update of the
ACC/AHA 2004 guidelines for the management of patients with
ST-elevation myocardial infarction: A report of the American
college of cardiology/American heart association task force on
practice guidelines. J Am Coll Cardiol. 51:210–247. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stenestrand U, Lindbäck J and Wallentin L:
RIKS-HIA Registry: Long-term outcome of primary percutaneous
coronary intervention vs. prehospital and in-hospital thrombolysis
for patients with ST-elevation myocardial infarction. JAMA.
296:1749–1756. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buja LM: Myocardial ischemia and
reperfusion injury. Cardiovasc Pathol. 14:170–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takemura G, Nakagawa M, Kanamori H,
Minatoguchi S and Fujiwara H: Benefits of reperfusion beyond
infarct size limitation. Cardiovasc Res. 83:269–276. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Baines CP: How and when do myocytes die
during ischemia and reperfusion: The late phase. J Cardiovasc
Pharmacol Ther. 16:239–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eefting F, Rensing B, Wigman J, Pannekoek
WJ, Liu WM, Cramer MJ, Lips DJ and Doevendans PA: Role of apoptosis
in reperfusion injury. Cardiovasc Res. 61:414–426. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jozkowicz A, Dulak J, Piatkowska E, Placha
W and Dembinska-Kiec A: Ligands of peroxisome
proliferator-activated receptor-gamma increase the generation of
vascular endothelial growth factor in vascular smooth muscle cells
and in macrophages. Acta Biochim Pol. 47:1147–1157. 2000.
|
|
8
|
Mersmann J, Tran N, Zacharowski PA,
Grotemeyer D and Zacharowski K: Rosiglitazone is cardioprotective
in a murine model of myocardial I/R. Shock. 30:64–68.
2008.PubMed/NCBI
|
|
9
|
Goyal S, Arora S, Bhatt TK, Das P, Sharma
A, Kumari S and Arya DS: Modulation of PPAR-gamma by telmisartan
protects the heart against myocardial infarction in experimental
diabetes. Chem Biol Interact. 185:271–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yasuda S, Kobayashi H, Iwasa M, Kawamura
I, Sumi S, Narentuoya B, Yamaki T, Ushikoshi H, Nishigaki K,
Nagashima K, et al: Antidiabetic drug pioglitazone protects the
heart via activation of PPAR-gamma receptors, PI3-kinase, Akt and
eNOS pathway in a rabbit model of myocardial infarction. Am J
Physiol Heart Circ Physiol. 296:H1558–H1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kilter H, Werner M, Roggia C, Reil JC,
Schäfers HJ, Kintscher U and Böhm M: The PPAR-gamma agonist
rosiglitazone facilitates Akt rephosphorylation and inhibits
apoptosis in cardiomyocytes during hypoxia/reoxygenation. Diabetes
Obes Metab. 11:1060–1067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ye Y, Hu Z, Lin Y, Zhang C and Perez-Polo
JR: Downregulation of microRNA-29 by antisense inhibitors and a
PPAR-gamma agonist protects against myocardial
ischaemia-reperfusion injury. Cardiovasc Res. 87:535–544. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ou HC, Lee WJ, Lee SD, Huang CY, Chiu TH,
Tsai KL, Hsu WC and Sheu WH: Ellagic acid protects endothelial
cells from oxidized low-density lipoprotein-induced apoptosis by
modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol.
248:134–143. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mott JL, Kobayashi S, Bronk SF and Gores
GJ: mir-29 regulates Mcl-1 protein expression and apoptosis.
Oncogene. 26:6133–6140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hullinger TG, Montgomery RL, Seto AG,
Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C,
Latimer PA, et al: Inhibition of miR-15 protects against cardiac
ischemic injury. Circ Res. 110:71–81. 2012. View Article : Google Scholar :
|
|
16
|
Lin Q, Gao Z, Alarcon RM, Ye J and Yun Z:
A role of miR-27 in the regulation of adipogenesis. FEBS J.
276:2348–2358. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang J, Song Y, Zhang Y, Xiao H, Sun Q,
Hou N, Guo S, Wang Y, Fan K, Zhan D, et al: Cardiomyocyte
overexpression of miR-27b induces cardiac hypertrophy and
dysfunction in mice. Cell Res. 22:516–527. 2012. View Article : Google Scholar :
|
|
18
|
Lee EK, Lee MJ, Abdelmohsen K, Kim W, Kim
MM, Srikantan S, Martindale JL, Hutchison ER, Kim HH, Marasa BS, et
al: miR-130 suppresses adipogenesis by inhibiting peroxisome
proliferator-activated receptor gamma expression. Mol Cell Biol.
31:626–638. 2011. View Article : Google Scholar
|
|
19
|
Pan S, Yang X, Jia Y, Li R and Zhao R:
Microvesicle-shuttled miR-130b reduces fat deposition in recipient
primary cultured porcine adipocytes by inhibiting PPAR-g
expression. J Cell Physiol. 229:631–639. 2014. View Article : Google Scholar
|
|
20
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng XC, Li XS and Wen H: Telmisartan
protects against microvascular dysfunction during myocardial
ischemia/reperfusion injury by activation of peroxisome
proliferator-activated receptor γ. BMC Cardiovasc Disord.
13:392013. View Article : Google Scholar
|
|
22
|
Maass AH and Buvoli M: Cardiomyocyte
preparation, culture and gene transfer. Methods Mol Biol.
366:321–330. 2007. View Article : Google Scholar
|
|
23
|
Krützfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with 'antagomirs'. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ren XP, Wu J, Wang X, Sartor MA, Qian J,
Jones K, Nicolaou P, Pritchard TJ and Fan GC: MicroRNA-320 is
involved in the regulation of cardiac ischemia/reperfusion injury
by targeting heat-shock protein 20. Circulation. 119:2357–2366.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Herrera BM, Lockstone HE, Taylor JM, Wills
QF, Kaisaki PJ, Barrett A, Camps C, Fernandez C, Ragoussis J,
Gauguier D, et al: MicroRNA-125a is over-expressed in insulin
target tissues in a spontaneous rat model of Type 2 diabetes. BMC
Med Genomics. 2:542009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shan H, Li X, Pan Z, Zhang L, Cai B, Zhang
Y, Xu C, Chu W, Qiao G, Li B, et al: Tanshinone IIA protects
against sudden cardiac death induced by lethal arrhythmias via
repression of microRNA-1. Br J Pharmacol. 158:1227–1235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong JQ, Zhang W, Gao H, Li Y, Zhong M,
Li D, Zhang C and Zhang Y: Changes in connexin 43,
metalloproteinase and tissue inhibitor of metalloproteinase during
tachycardia-induced cardiomyopathy in dogs. Eur J Heart Fail.
9:23–29. 2007. View Article : Google Scholar
|
|
29
|
Li R, Yan G, Li Q, Sun H, Hu Y, Sun J and
Xu B: MicroRNA-145 protects cardiomyocytes against hydrogen
peroxide (H2O2)-induced apoptosis through
targeting the mitochondria apoptotic pathway. PLoS One.
7:e449072012. View Article : Google Scholar
|
|
30
|
Wang X, Ha T, Liu L, Zou J, Zhang X,
Kalbfleisch J, Gao X, Williams D and Li C: Increased expression of
microRNA-146a decreases myocardial ischaemia/reperfusion injury.
Cardiovasc Res. 97:432–442. 2013. View Article : Google Scholar :
|
|
31
|
Liu H, Guo X, Chu Y and Lu S: Heart
protective effects and mechanism of quercetin preconditioning on
anti-myocardial ischemia reperfusion (IR) injuries in rats. Gene.
545:149–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ren-an Q, Juan L, Chuyuan L, Wenjuan F,
Chunyan H, Xuemei Y, Lin H and Hong N: Study of the protective
mechanisms of compound Danshen tablet (Fufang Danshen Pian) against
myocardial ischemia/reperfusion injury via the Akt-eNOS signaling
pathway in rats. J Ethnopharmacol. 156:190–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fulton D, Gratton JP, McCabe TJ, Fontana
J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A and Sessa WC:
Regulation of endothelium-derived nitric oxide production by the
protein kinase Akt. Nature. 399:597–601. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Limaye V, Li X, Hahn C, Xia P, Berndt MC,
Vadas MA and Gamble JR: Sphingosine kinase-1 enhances endothelial
cell survival through a PECAM-1-dependent activation of PI-3K/Akt
and regulation of Bcl-2 family members. Blood. 105:3169–3177. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thomas RL, Roberts DJ, Kubli DA, Lee Y,
Quinsay MN, Owens JB, Fischer KM, Sussman MA, Miyamoto S and
Gustafsson ÅB: Loss of MCL-1 leads to impaired autophagy and rapid
development of heart failure. Genes Dev. 27:1365–1377. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang X, Bathina M, Lynch J, Koss B,
Calabrese C, Frase S, Schuetz JD, Rehg JE and Opferman JT: Deletion
of MCL-1 causes lethal cardiac failure and mitochondrial
dysfunction. Genes Dev. 27:1351–1364. 2013. View Article : Google Scholar : PubMed/NCBI
|
